Pronóstico del mercado de opioides en América del Sur y Central hasta 2030: análisis regional, por producto (opioide de liberación inmediata de acción corta y opioide de liberación prolongada de acción prolongada), aplicación (manejo del dolor, anestesia, supresión de la diarrea, supresión de la tos, desintoxicación y otros), vía de administración (parche oral, inyectable y transdérmico) y canal de distribución (farmacias de hospitales y farmacias minoristas)
El aumento de la población geriátrica impulsa el mercado de opioides de América del Sur y Central
La mayoría de las personas mayores viven con dolor crónico, lo que resulta en una reducción de la fuerza para llevar a cabo su rutina diaria. La población geriátrica sufre ampliamente trastornos de los huesos y las articulaciones, artritis, cáncer y otros trastornos crónicos que causan dolor. Según los datos de la Organización Mundial de la Salud (OMS) de febrero de 2018, se estima que la población geriátrica crecerá un 22% para 2050 en comparación con el 12% en 2015. Los datos también indicaron que los países de ingresos bajos y medios representarían casi el 80% de este aumento. Varios países desarrollados también están experimentando un crecimiento significativo en la población geriátrica, que es impulsado por mejores instalaciones de atención médica y mejores servicios de atención médica; esto ha resultado en un aumento de la esperanza de vida en estas regiones. Una población que envejece impulsa el mercado de opioides principalmente a través de una mayor demanda de soluciones para el manejo del dolor. Además, los adultos mayores a menudo se someten a cirugías y procedimientos médicos que requieren el manejo del dolor. Por lo tanto, la creciente población geriátrica en toda la región impulsa el crecimiento del mercado de opioides.
Resumen del mercado de opioides en América del Sur y Central
Según los datos de la Organización Panamericana de la Salud (OPS), más de 30 millones de personas en Brasil tienen 60 años o más, lo que representa el 13% de la población del país. Para 2030, se espera que este recuento alcance ~ 50 millones, lo que representa el 24% de la población brasileña. Según el Instituto Brasileño de Geografía y Estadística, se espera que la población del país de 65 años o más represente una participación del 36% de la población total de Brasil para 2050. El dolor crónico es una de las afecciones más comunes que afectan a los adultos mayores. Las personas que padecen esta afección prefieren usar productos opioides, lo que lleva a un aumento de las prescripciones de opioides.
Según la Agencia Nacional de Vigilancia Sanitaria (ANVISA) y los sistemas hospitalarios privados brasileños, Brasil se vio gravemente afectado por el inicio de la pandemia de COVID-19, con 700.000 muertes en abril de 2022. Las condiciones de salud de sus ciudadanos empeoraron por los retrasos en la disponibilidad de la vacuna, lo que provocó altas tasas de hospitalización y ventilación para casos graves que aceleraron la demanda de fentanilo, utilizado como sedante durante la intubación, según la Agencia Nacional de Vigilancia Sanitaria (ANVISA) y los sistemas hospitalarios privados brasileños.
Además, según los datos publicados en The Lancet Regional Health-Americas en abril de 2023, ha habido un aumento en el uso de opioides recetados en Brasil en las últimas dos décadas, incluso con fines médicos y no médicos, lo que está impulsando el mercado en Brasil.
Ingresos del mercado de opioides de América del Sur y Central y pronóstico hasta 2030 (millones de USD)
Segmentación del mercado de opioides de América del Sur y Central
El mercado de opioides de América del Sur y Central se clasifica en producto, aplicación, vía de administración, canal de distribución y país.
Según el producto, el mercado de opioides de América del Sur y Central está segmentado en opioides de acción corta de liberación inmediata y opioides de acción prolongada de liberación prolongada. El segmento de opioides de acción corta de liberación inmediata tuvo una mayor participación de mercado en 2022. El opioide de acción corta de liberación inmediata se subsegmenta en oxicodona, hidrocodona, tramadol, codina, propoxifeno y otros. El opioide de liberación prolongada de acción prolongada se subdivide en oxicodona, fentanilo, morfina, metadona y otros.
En términos de aplicación, el mercado de opioides de América del Sur y Central se clasifica en manejo del dolor, anestesia, supresión de la diarrea, supresión de la tos, desintoxicación y otros. El segmento de manejo del dolor tuvo la mayor participación de mercado en 2022.
Por vía de administración, el mercado de opioides de América del Sur y Central se segmenta en parches orales, inyectables y transdérmicos. El segmento oral tuvo la mayor participación de mercado en 2022.
Por canal de distribución, el mercado de opioides de América del Sur y Central se bifurca en farmacias hospitalarias y farmacias minoristas. El segmento de farmacias hospitalarias tuvo una mayor participación de mercado en 2022.
Por país, el mercado de opioides de América del Sur y Central está segmentado en Brasil, Argentina y el resto de LATUM. Brasil dominó la participación de mercado de opioides en América del Sur y Central en 2022.
Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Rusan Pharma Ltd y Teva Pharmaceutical Industries Ltd son algunas de las empresas líderes que operan en el mercado de opioides de América del Sur y Central.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - South & Central America Analysis
5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030
5.2 South & Central America Opioids Market Forecast Analysis
6. South & Central America Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. South & Central America Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Opioids Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product
10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application
10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product
10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application
10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product
10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application
10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration
10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rusan Pharma Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Opioids Market Segmentation
Table 2. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Recent Organic Growth Strategies in Opioids Market
Table 29. Recent Inorganic Growth Strategies in the Opioids Market
Table 30. Glossary of Terms, Opioids Market
List of Figures
Figure 1. South & Central America Opioids Market Segmentation, by Country
Figure 2. South & Central America Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. South & Central America Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.